Annual CAPEX
$30.58 M
-$68.81 M-69.23%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual capital expenditures is $30.58 million, with the most recent change of -$68.81 million (-69.23%) on December 31, 2023.
- During the last 3 years, IBRX annual CAPEX has risen by +$28.91 million (+1732.47%).
- IBRX annual CAPEX is now -69.23% below its all-time high of $99.39 million, reached on December 31, 2022.
Performance
IBRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$2.79 M
+$2.07 M+285.64%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly capital expenditures is $2.79 million, with the most recent change of +$2.07 million (+285.64%) on September 30, 2024.
- Over the past year, IBRX quarterly CAPEX has increased by +$2.07 million (+285.64%).
- IBRX quarterly CAPEX is now -94.25% below its all-time high of $48.58 million, reached on March 31, 2022.
Performance
IBRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$12.73 M
-$2.88 M-18.46%
September 30, 2024
Summary
- As of February 12, 2025, IBRX TTM capital expenditures is $12.73 million, with the most recent change of -$2.88 million (-18.46%) on September 30, 2024.
- Over the past year, IBRX TTM CAPEX has dropped by -$2.88 million (-18.46%).
- IBRX TTM CAPEX is now -87.19% below its all-time high of $99.39 million, reached on December 31, 2022.
Performance
IBRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IBRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.2% | +285.6% | -18.5% |
| 3 y3 years | +1732.5% | -67.3% | -75.4% |
| 5 y5 years | +613.4% | -67.3% | -75.4% |
IBRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.2% | at low | -94.3% | +285.6% | -87.2% | at low |
| 5 y | 5-year | -69.2% | +1732.5% | -94.3% | +499.4% | -87.2% | +3941.9% |
| alltime | all time | -69.2% | +1732.5% | -94.3% | +499.4% | -87.2% | +3941.9% |
ImmunityBio CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.79 M(+285.6%) | $12.73 M(-18.5%) |
| Jun 2024 | - | $724.00 K(-42.6%) | $15.62 M(-33.3%) |
| Mar 2024 | - | $1.26 M(-84.1%) | $23.42 M(-23.4%) |
| Dec 2023 | $30.58 M(-69.2%) | $7.96 M(+40.2%) | $30.58 M(-26.4%) |
| Sep 2023 | - | $5.67 M(-33.4%) | $41.56 M(-19.8%) |
| Jun 2023 | - | $8.53 M(+1.2%) | $51.82 M(-12.5%) |
| Mar 2023 | - | $8.43 M(-55.5%) | $59.24 M(-40.4%) |
| Dec 2022 | $99.39 M | $18.93 M(+18.8%) | $99.39 M(+9.4%) |
| Sep 2022 | - | $15.94 M(-0.1%) | $90.86 M(+9.5%) |
| Jun 2022 | - | $15.95 M(-67.2%) | $82.96 M(+10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $48.58 M(+366.9%) | $75.06 M(+123.6%) |
| Dec 2021 | $33.56 M(+1911.0%) | $10.40 M(+29.5%) | $33.56 M(+49.4%) |
| Sep 2021 | - | $8.03 M(-0.2%) | $22.46 M(+36.4%) |
| Jun 2021 | - | $8.04 M(+13.6%) | $16.47 M(+95.2%) |
| Mar 2021 | - | $7.08 M(-1113.3%) | $8.44 M(+405.5%) |
| Dec 2020 | $1.67 M(-61.1%) | -$699.00 K(-134.2%) | $1.67 M(-29.5%) |
| Sep 2020 | - | $2.04 M(>+9900.0%) | $2.37 M(+630.9%) |
| Jun 2020 | - | $9000.00(-97.1%) | $324.00 K(+2.9%) |
| Mar 2020 | - | $315.00 K | $315.00 K |
| Dec 2019 | $4.29 M | - | - |
FAQ
- What is ImmunityBio annual capital expenditures?
- What is the all time high annual CAPEX for ImmunityBio?
- What is ImmunityBio annual CAPEX year-on-year change?
- What is ImmunityBio quarterly capital expenditures?
- What is the all time high quarterly CAPEX for ImmunityBio?
- What is ImmunityBio quarterly CAPEX year-on-year change?
- What is ImmunityBio TTM capital expenditures?
- What is the all time high TTM CAPEX for ImmunityBio?
- What is ImmunityBio TTM CAPEX year-on-year change?
What is ImmunityBio annual capital expenditures?
The current annual CAPEX of IBRX is $30.58 M
What is the all time high annual CAPEX for ImmunityBio?
ImmunityBio all-time high annual capital expenditures is $99.39 M
What is ImmunityBio annual CAPEX year-on-year change?
Over the past year, IBRX annual capital expenditures has changed by -$68.81 M (-69.23%)
What is ImmunityBio quarterly capital expenditures?
The current quarterly CAPEX of IBRX is $2.79 M
What is the all time high quarterly CAPEX for ImmunityBio?
ImmunityBio all-time high quarterly capital expenditures is $48.58 M
What is ImmunityBio quarterly CAPEX year-on-year change?
Over the past year, IBRX quarterly capital expenditures has changed by +$2.07 M (+285.64%)
What is ImmunityBio TTM capital expenditures?
The current TTM CAPEX of IBRX is $12.73 M
What is the all time high TTM CAPEX for ImmunityBio?
ImmunityBio all-time high TTM capital expenditures is $99.39 M
What is ImmunityBio TTM CAPEX year-on-year change?
Over the past year, IBRX TTM capital expenditures has changed by -$2.88 M (-18.46%)